Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter

TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake Watch Now

TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential


Glaxosmithkline Share News (GSK)

Stock Market news at lse.co.uk - RSS News Feeds

Share News for Glaxosmithkline (GSK)


Share Price: 1,584.40Bid: 1,587.00Ask: 1,587.20Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.20Spread as %: 0.01%Open: 1,567.00High: 0.00Low: 0.00Yesterday’s Close: 1,584.40




Ex-divs to take 23.6 points off FTSE 100 on May 16

Mon, 13th May 2019 09:55

MILAN, May 13 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-makers would take 23.6 points off the index. (RIC) COMPANY DIVIDEND STOCK IMPACT (pence) OPTION GLAXOSMITHKLINE 19 3.68 HSBC HOLDINGS 0.1 (USD) Yes 6.14 INTERTEK GROUP 67.2 0.43 RDS 'A 0.47 (USD) 6.4 RDS 'B 47 (USc) 5.38 TESCO 4.1 1.57 Among FTSE 250 companies going ex-dividend are: (RIC) COMPANY DIVIDEND (pence) ASCENTIAL 3.9 BALFOUR BEATTY 3.2 BLACKROCK SML 19.2 CLARKSON 51 CIVITAS SOCIAL 1.06 F&C COMM PRP 0.5 FIDELITY SPECIAL 2.1 HOCHSCHILD 1.959 (USc) INCHCAPE 17.9 PAGEGROUP 9 SAGA 1 TED BAKER 40.7 RENEWABLES 1.66 UK COMM PROP TST 0.74 VIVO ENERGY 0.013 (USD) (Reporting by Danilo Masoni; editing by Josephine Mason)



(c) Copyright Thomson Reuters 2019. Click For Restrictions - https://agency.reuters.com/en/copyright.html







Germany's Stada buys six of GSK's consumer brands, eyes further deals

FRANKFURT, June 7 (Reuters) - Private equity-backed generic drugmaker Stada said on Friday it would buy six consumer healthcare products from British
[7 Jun '19 09:01]

Trump strikes "supportive" tone in meeting with British business leaders -sources

By Lawrence White and Siddharth CavaleLONDON, June 4 (Reuters) - U.S. President Donald Trump struck a positive, conciliatory tone with top British and
[4 Jun '19 15:09]

UK cross-border M&A activity slumps in early 2019

LONDON, June 4 (Reuters) - The value of cross-border company takeovers in Britain fell sharply in the first three months of 2019 as the number of acqu
[4 Jun '19 09:36]

UPDATE 2-FTSE 100 higher as trade respite lifts banks, miners

* FTSE 100 up 0.4%, FTSE 250 up 0.7%* Banks, miners top boosts* Hargreaves Lansdown down after fund suspended* Retailers hit after consumer spending s
[4 Jun '19 09:26]

GSK's Nucala wins European panel thumbs-up for self-administration

June 4 (Reuters) - GlaxoSmithKline said on Tuesday it had won marketing approval from a European Medicines Agency (EMA) panel for its Nucala drug to b
[4 Jun '19 08:20]

Let's deepen economic ties, Britain's May tells Trump

LONDON, June 3 (Reuters) - British Prime Minister Theresa May will call on U.S. President Donald Trump to deepen transatlantic economic cooperation on
[3 Jun '19 22:30]

UPDATE 2-Pharma stocks aid turnaround in FTSE 100; profit alert sinks Kier

* FTSE 100 up 0.3%* FTSE 250 down 0.5%* Pharma, consumers biggest boosts to main index* Kier at 2 decade low after profit alert (Adds company news ite
[3 Jun '19 09:12]

UPDATE 1-Lynparza stalls pancreatic cancer in patients with BRCA mutations -study

(Adds comments from AstraZeneca executive, PIX available)By Julie SteenhuysenCHICAGO, June 2 (Reuters) - AstraZeneca and Merck & Co's Lynparza helped
[2 Jun '19 18:10]



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.